Brief: Zivo Bioscience Regains Compliance Following Receipt Of Noncompliance Notice From Nasdaq
25/04/2022 21:06
April 25 (Reuters) - Zivo Bioscience Inc ZIVO.O :
* ZIVO BIOSCIENCE REGAINS COMPLIANCE FOLLOWING RECEIPT OF
NONCOMPLIANCE NOTICE FROM NASDAQ
* ZIVO BIOSCIENCE INC -ON APRIL 22, 2022, CO FULLY REGAINED
COMPLIANCE WITH NASDAQ CONTINUED LISTING REQUIREMENTS AS A
RESULT OF FILING FORM 10-K
Source text for Eikon: ID:nBw3jKzGma
Further company coverage: ZIVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens